[Endocrine therapy combined with mTOR inhibitor for hormone receptor-positive breast cancer].
Yu
Y
Zong
Kun-wei
KW
Shen
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011960:Receptors, Estrogen / Q000378:metabolism; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
D004791:Enzyme Inhibitors; D011960:Receptors, Estrogen; D058570:TOR Serine-Threonine Kinases